The wikitext annotated image, with reactions and enzymes noted for the paths, is located at en:Template:Bicalutamide metabolism.

Diagram references:

• This review covers the metabolism of bicalutamide along the illustrated pathways and the in vitro hydroxylation of bicalutamide by the human CYP3A4 isoenzyme:

  (2004). "Bicalutamide: clinical pharmacokinetics and metabolism". Clinical Pharmacokinetics 43 (13): 855–878. DOI:10.2165/00003088-200443130-00003. PMID 15509184. "These data indicate that direct glucuronidation is the main metabolic pathway for the rapidly cleared (S)-bicalutamide, whereas hydroxylation followed by glucuronidation is a major metabolic pathway for the slowly cleared (R)-bicalutamide."

• This paper covers the in vitro glucuronidation of (S)-bicalutamide and (R)-hydroxybicalutamide by the human UGT1A9 enzyme:

  (August 2013). "Enantiomer selective glucuronidation of the non-steroidal pure anti-androgen bicalutamide by human liver and kidney: role of the human UDP-glucuronosyltransferase (UGT)1A9 enzyme". Basic & Clinical Pharmacology & Toxicology 113 (2): 92–102. DOI:10.1111/bcpt.12071. PMID 23527766. PMC: 3815647.